Dualsystems Biotech is a proteomics company located in Schlieren, Switzerland. We are a leading European Biotech company in the field of interactive proteomics using proprietary technologies including genetic screening in yeast, screening for protein-protein interactions, yeast expression systems and construction of cDNA libraries. The company offers screening services to academic and industrial customers worldwide and also markets a range of innovative products to help its customers improve their in-house screening platforms.
Dualsystems has filed several patents to protect its technologies.
Dualsystems technologies are aimed at accelerating basic research and to speed up drug development by identifying novel drug targets. Dualsystems service department currently provides a diversified set of customised services for the identification of protein interactions in vivo: www.dualsystems.com/products/services.asp
Dualsystems comprehensive range of screening kits and yeast expression tools offers a one-stop shop solution for studying protein-protein interactions in yeast. These include conventional yeast two-hybrid systems, the proprietary DUALmembrane system, yeast reporter strains and pre-made or custom-made cDNA libraries: www.dualsystems.com/products/families.asp
Dualsystems unique technology platform allows the study of diseases which are not identifiable with currently available technologies. A major goal of the company is therefore to develop its technologies to a point where they bridge the gap between information about protein-protein interactions and drug discovery. Furthermore, Dualsystems will continue to optimise and enhance its success-fully running protein-protein interaction screening service for Academia, Biotech and Pharmaceutical companies.